The role of proteases in regulating Eph/ephrin signaling

References

• Serim S, Haedke U, Verhelst SHL. Activity-based probes for the study of proteases: recent advances and developments. ChemMedChem 2012; 7:1146-59; PMID:22431376; http://dx.doi.org/10.1002/cmdc.201200057
   PubMedGoogle Scholar
• Drag M, Salvesen GS. Emerging principles in protease-based drug discovery. Nat Rev Drug Discov 2010; 9:690-701; PMID:20811381; http://dx.doi.org/10.1038/nrd3053
   PubMed Web of Science ®Google Scholar
• Turk B. Targeting proteases: successes, failures and future prospects. Nat Rev Drug Dis 2006; 5:785-99; PMID:16955069; http://dx.doi.org/10.1038/nrd2092
   PubMed Web of Science ®Google Scholar
• Lopez-Otin C, Bond JS. Proteases: multifunctional enzymes in life and disease. J Biol Chem 2008; 283:30433-7; PMID:18650443; http://dx.doi.org/10.1074/jbc.R800035200
   PubMed Web of Science ®Google Scholar
• Overall CM, Blobel CP. In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol 2007; 8:245-57; PMID:17299501; http://dx.doi.org/10.1038/nrm2120
   PubMed Web of Science ®Google Scholar
• Turk B, Turk D, Turk V. Protease signalling: the cutting edge. EMBO J 2012; 31:1630-43; PMID:22367392; http://dx.doi.org/10.1038/emboj.2012.42
   PubMed Web of Science ®Google Scholar
• Adrain C, Freeman M. Regulation of receptor tyrosine kinase ligand processing. Cold Spring Harb Perspect Biol 2014; 6:pii: a008995; PMID:24384567; http://dx.doi.org/10.1101/cshperspect.a008995
   PubMedGoogle Scholar
• Nievergall E, Lackmann M, Janes PW. Eph-dependent cell-cell adhesion and segregation in development and cancer. Cell Mol Life Sci 2012; 69:1813-42; PMID:22204021; http://dx.doi.org/10.1007/s00018-011-0900-6
   PubMed Web of Science ®Google Scholar
• Marston DJ, Dickinson S, Nobes CD. Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat Cell Biol 2003; 5:879-88; PMID:12973357; http://dx.doi.org/10.1038/ncb1044
   PubMed Web of Science ®Google Scholar
• Klein T, Bischoff R. Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure. J Proteome Res 2011; 10:17-33; PMID:20849079; http://dx.doi.org/10.1021/pr100556z
   PubMed Web of Science ®Google Scholar
• Wolfsberg TG, White JM. 207–ADAM metalloproteinases. In: Barrett AJ, Rawlings ND, Woessner JF, eds. Handbook of Proteolytic Enzymes. Second Edition. London: Academic Press, 2004:709-14
   Google Scholar
• Weber S, Saftig P. Ectodomain shedding and ADAMs in development. Development (Cambridge, England) 2012; 139:3693-709; PMID:22991436; http://dx.doi.org/10.1242/dev.076398
   PubMed Web of Science ®Google Scholar
• Reiss K, Saftig P. The “a disintegrin and metalloprotease” (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol 2009; 20:126-37; PMID:19049889; http://dx.doi.org/10.1016/j.semcdb.2008.11.002
   PubMed Web of Science ®Google Scholar
• Tousseyn T, Jorissen E, Reiss K, Hartmann D. (Make) stick and cut loose–disintegrin metalloproteases in development and disease. Birth Defects Res C Embryo Today 2006; 78:24-46; PMID:16622847; http://dx.doi.org/10.1002/bdrc.20066
   PubMedGoogle Scholar
• Kurohara K, Komatsu K, Kurisaki T, Masuda A, Irie N, Asano M, Sudo K, Nabeshima Y, Iwakura Y, Sehara-Fujisawa A. Essential roles of Meltrin beta (ADAM19) in heart development. Dev Biol 2004; 267:14-28; PMID:14975714; http://dx.doi.org/10.1016/j.ydbio.2003.10.021
   PubMed Web of Science ®Google Scholar
• Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 2008; 8:929-41; PMID:19005493; http://dx.doi.org/10.1038/nrc2459
   PubMed Web of Science ®Google Scholar
• Blobel CP. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 2005; 6:32-43; PMID:15688065; http://dx.doi.org/10.1038/nrm1548
   PubMed Web of Science ®Google Scholar
• Loechel F, Overgaard MT, Oxvig C, Albrechtsen R, Wewer UM. Regulation of human ADAM 12 protease by the prodomain. Evidence for a functional cysteine switch. J Biol Chem 1999; 274:13427-33; PMID:10224107; http://dx.doi.org/10.1074/jbc.274.19.13427
   PubMed Web of Science ®Google Scholar
• Anders A, Gilbert S, Garten W, Postina R, Fahrenholz F. Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J 2001; 15:1837-9; PMID:11481247
   PubMed Web of Science ®Google Scholar
• Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 2003; 17:7-30; PMID:12514095; http://dx.doi.org/10.1101/gad.1039703
   PubMed Web of Science ®Google Scholar
• Fahrenholz F, Gilbert S, Kojro E, Lammich S, Postina R. Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure. Ann N Y Acad Sci 2000; 920:215-22; PMID:11193153; http://dx.doi.org/10.1111/j.1749-6632.2000.tb06925.x
   PubMed Web of Science ®Google Scholar
• Howard L, Maciewicz RA, Blobel CP. Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28. Biochem J 2000; 348 Pt 1:21-7; PMID:10794709; http://dx.doi.org/10.1042/0264-6021:3480021
   PubMedGoogle Scholar
• Roghani M, Becherer JD, Moss ML, Atherton RE, Erdjument-Bromage H, Arribas J, Blackburn RK, Weskamp G, Tempst P, Blobel CP. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J Biol Chem 1999; 274:3531-40; PMID:9920899; http://dx.doi.org/10.1074/jbc.274.6.3531
   PubMed Web of Science ®Google Scholar
• Lum L, Reid MS, Blobel CP. Intracellular maturation of the mouse metalloprotease disintegrin MDC15. J Biol Chem 1998; 273:26236-47; PMID:9748307; http://dx.doi.org/10.1074/jbc.273.40.26236
   PubMed Web of Science ®Google Scholar
• Laisney JAGC, Mueller TD, Schartl M, Meierjohann S. Hyperactivation of constitutively dimerized oncogenic EGF receptors by autocrine loops. Oncogene 2013; 32:2403-11; PMID:22751127; http://dx.doi.org/10.1038/onc.2012.267
   PubMedGoogle Scholar
• Moss ML, Bomar M, Liu Q, Sage H, Dempsey P, Lenhart PM, Gillispie PA, Stoeck A, Wildeboer D, Bartsch JW, et al. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem 2007; 282:35712-21; PMID:17895248; http://dx.doi.org/10.1074/jbc.M703231200
   PubMed Web of Science ®Google Scholar
• Loechel F, Gilpin BJ, Engvall E, Albrechtsen R, Wewer UM. Human ADAM 12 (meltrin alpha) is an active metalloprotease. J Biol Chem 1998; 273:16993-7; PMID:9642263; http://dx.doi.org/10.1074/jbc.273.27.16993
   PubMed Web of Science ®Google Scholar
• Saftig P, Reiss K. The “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur J Cell Biol 2011; 90:527-35; PMID:21194787; http://dx.doi.org/10.1016/j.ejcb.2010.11.005
   PubMed Web of Science ®Google Scholar
• White JM. ADAMs: modulators of cell–cell and cell–matrix interactions. Curr Opin Cell Biol 2003; 15:598-606; PMID:14519395; http://dx.doi.org/10.1016/j.ceb.2003.08.001
   PubMed Web of Science ®Google Scholar
• Caescu CI, Jeschke GR, Turk BE. Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem J 2009; 424:79-88; PMID:19715556; http://dx.doi.org/10.1042/BJ20090549
   PubMed Web of Science ®Google Scholar
• Moss ML, Lambert MH. Shedding of membrane proteins by ADAM family proteases. Essays Biochem 2002; 38:141-53; PMID:12463167
   PubMed Web of Science ®Google Scholar
• Smith KM, Gaultier A, Cousin H, Alfandari D, White JM, DeSimone DW. The cysteine-rich domain regulates ADAM protease function in vivo. J Cell Biol 2002; 159:893-902; PMID:12460986; http://dx.doi.org/10.1083/jcb.200206023
   PubMed Web of Science ®Google Scholar
• Alfandari D. ADAM13 Function in Development. In: Hooper N, Lendeckel U, eds. The ADAM Family of Proteases: Springer US, 2005:147-69
   Google Scholar
• Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Shows D, Peschon JJ, Black RA. Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme. J Biol Chem 2000; 275:14608-14; PMID:10799547; http://dx.doi.org/10.1074/jbc.275.19.14608
   PubMed Web of Science ®Google Scholar
• Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, Blobel CP, Himanen JP, Lackmann M, Nikolov DB. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 2005; 123:291-304; PMID:16239146; http://dx.doi.org/10.1016/j.cell.2005.08.014
   PubMed Web of Science ®Google Scholar
• Maskos K, Fernandez-Catalan C, Huber R, Bourenkov GP, Bartunik H, Ellestad GA, Reddy P, Wolfson MF, Rauch CT, Castner BJ, et al. Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme. Proc Natl Acad Sci U S A 1998; 95:3408-12; PMID:9520379; http://dx.doi.org/10.1073/pnas.95.7.3408
   PubMed Web of Science ®Google Scholar
• Takeda S, Igarashi T, Mori H, Araki S. Crystal structures of VAP1 reveal ADAMs’ MDC domain architecture and its unique C-shaped scaffold. EMBO J 2006; 25:2388-96; PMID:16688218; http://dx.doi.org/10.1038/sj.emboj.7601131
   PubMedGoogle Scholar
• Kullander K, Klein R. Mechanisms and functions of eph and ephrin signalling. Nat Rev Mol Cell Biol 2002; 3:475-86; PMID:12094214; http://dx.doi.org/10.1038/nrm856
   PubMed Web of Science ®Google Scholar
• Hattori M, Osterfield M, Flanagan JG. Regulated cleavage of a contact-mediated axon repellent. Science 2000; 289:1360-5; PMID:10958785; http://dx.doi.org/10.1126/science.289.5483.1360
   PubMed Web of Science ®Google Scholar
• Sahin U, Weskamp G, Kelly K, Zhou H-M, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004; 164:769-79; PMID:14993236; http://dx.doi.org/10.1083/jcb.200307137
   PubMed Web of Science ®Google Scholar
• Luo X, Prior M, He W, Hu X, Tang X, Shen W, Yadav S, Kiryu-Seo S, Miller R, Trapp s, et al. Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination. J Biol Chem 2011; 286:23967-74; PMID:21576249; http://dx.doi.org/10.1074/jbc.M111.251538
   PubMed Web of Science ®Google Scholar
• Pruessmeyer J, Ludwig A. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin Cell Dev Biol 2009; 20:164-74; PMID:18951988; http://dx.doi.org/10.1016/j.semcdb.2008.09.005
   PubMed Web of Science ®Google Scholar
• Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 2004; 172:6362-72; PMID:15128827; http://dx.doi.org/10.4049/jimmunol.172.10.6362
   PubMed Web of Science ®Google Scholar
• Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003; 102:1186-95; PMID:12714508; http://dx.doi.org/10.1182/blood-2002-12-3775
   PubMed Web of Science ®Google Scholar
• Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, de Strooper B, Hartmann D, Saftig P. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and β-catenin translocation. Proc Natl Acad Sci U S A 2005; 102:9182-7; PMID:15958533; http://dx.doi.org/10.1073/pnas.0500918102
   PubMed Web of Science ®Google Scholar
• Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, Hartmann D, Saftig P. ADAM10 cleavage of N-cadherin and regulation of cell–cell adhesion and β-catenin nuclear signalling. EMBO J 2005; 24:742–52.
   PubMed Web of Science ®Google Scholar
• Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Gast D, Joumaa S, Zentgraf H, Fogel M, Altevogt DP. ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 2003; 17:292-4; PMID:12475894
   PubMedGoogle Scholar
• Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, Ellwart JW, Kremmer E, Rossner S, Lichtenthaler SF. ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J 2010; 29:3020-32; PMID:20676056; http://dx.doi.org/10.1038/emboj.2010.167
   PubMed Web of Science ®Google Scholar
• Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J, Lopez-Perez E, Checler F. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 2001; 276:37743-6; PMID:11477090; http://dx.doi.org/10.1074/jbc.M003965200
   PubMedGoogle Scholar
• Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, Bickett DM, Leesnitzer MA, Becherer JD. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 2005; 8:161-71; PMID:15777180; http://dx.doi.org/10.2174/1386207053258488
   PubMed Web of Science ®Google Scholar
• Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7:678-89; PMID:16921404; http://dx.doi.org/10.1038/nrm2009
   PubMed Web of Science ®Google Scholar
• D’Souza B, Miyamoto A, Weinmaster G. The many facets of Notch ligands. Oncogene 2008; 27:5148-67; http://dx.doi.org/10.1038/onc.2008.229
   PubMed Web of Science ®Google Scholar
• Zolkiewska A. ADAM proteases: ligand processing and modulation of the Notch pathway. Cell Mol Life Sci 2008; 65:2056-68; PMID:18344021; http://dx.doi.org/10.1007/s00018-008-7586-4
   PubMed Web of Science ®Google Scholar
• Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lübke T, Lena Illert A, von Figura K, et al. The disintegrinmetalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 2002; 11:2615-24; PMID:12354787; http://dx.doi.org/10.1093/hmg/11.21.2615
   PubMed Web of Science ®Google Scholar
• Mancia F, Shapiro L. ADAM and Eph: how Ephrin-signaling cells become detached. Cell 2005; 123:185-7; PMID:16239135; http://dx.doi.org/10.1016/j.cell.2005.10.004
   PubMed Web of Science ®Google Scholar
• Salaita K, Nair PM, Petit RS, Neve RM, Das D, Gray JW, Groves JT. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science 2010; 327:1380-5; PMID:20223987; http://dx.doi.org/10.1126/science.1181729
   PubMed Web of Science ®Google Scholar
• Atapattu L, Saha N, Llerena C, Vail ME, Scott AM, Nikolov DB, Lackmann M, Janes PW. Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function. J Cell Sci 2012; 125:6084-93; PMID:23108669; http://dx.doi.org/10.1242/jcs.112631
   PubMed Web of Science ®Google Scholar
• Janes PW, Wimmer-Kleikamp SH, Frangakis AS, Treble K, Griesshaber B, Sabet O, Grabenbauer M, Ting AY, Saftig P, Bastiaens PI, et al. Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol 2009; 7:e1000215; PMID:19823572; http://dx.doi.org/10.1371/journal.pbio.1000215
   PubMedGoogle Scholar
• Wybenga-Groot LE, Baskin B, Ong SH, Tong J, Pawson T, Sicheri F. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 2001; 106:745-57; PMID:11572780; http://dx.doi.org/10.1016/S0092-8674(01)00496-2
   PubMed Web of Science ®Google Scholar
• Wang Y, Herrera AH, Li Y, Belani KK, Walcheck B. Regulation of mature ADAM17 by redox agents for L-selectin shedding. J Immunol 2009; 182:2449-57; PMID:19201900; http://dx.doi.org/10.4049/jimmunol.0802770
   PubMed Web of Science ®Google Scholar
• Willems SH, Tape CJ, Stanley PL, Taylor NA, Mills IG, Neal DE, McCafferty J, Murphy G, et al. Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem J 2010; 428:439-50; PMID:20345372; http://dx.doi.org/10.1042/BJ20100179
   PubMed Web of Science ®Google Scholar
• Dusterhoft S, Jung S, Hung CW, Tholey A, Sonnichsen FD, Grotzinger J, Lorenzen I. Membrane-proximal domain of a disintegrin and metalloprotease-17 represents the putative molecular switch of its shedding activity operated by protein-disulfide isomerase. J Am Chem Soc 2013; 135:5776-81; PMID:23521534; http://dx.doi.org/10.1021/ja400340u
   PubMed Web of Science ®Google Scholar
• Chiarugi P, Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci 2003; 28:509-14; PMID:13678963; http://dx.doi.org/10.1016/S0968-0004(03)00174-9
   PubMed Web of Science ®Google Scholar
• Chiarugi P, Buricchi F. Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications. Antioxid Redox Signal 2007; 9:1-24; PMID:17115885; http://dx.doi.org/10.1089/ars.2007.9.1
   PubMed Web of Science ®Google Scholar
• van Kempen LCL, de Visser KE, Coussens LM. Inflammation, proteases and cancer. Eur J Cancer 2006; 42:728-34; PMID:16524717; http://dx.doi.org/10.1016/j.ejca.2006.01.004
   PubMed Web of Science ®Google Scholar
• Hartmann M, Herrlich A, Herrlich P. Who decides when to cleave an ectodomain? Trends Biochem Sci 2013; 38:111-20; PMID:23298902; http://dx.doi.org/10.1016/j.tibs.2012.12.002
   PubMedGoogle Scholar
• Ji YJ, Hwang YS, Mood K, Cho HJ, Lee HS, Winterbottom E, Cousin H, Daar IO. EphrinB2 affects apical constriction in Xenopus embryos and is regulated by ADAM10 and flotillin-1. Nat Commun 2014; 5:3516; PMID:24662724
   PubMed Web of Science ®Google Scholar
• Gauthier LR, Robbins SM. Ephrin signaling: One raft to rule them all? One raft to sort them? One raft to spread their call and in signaling bind them? Life Sci 2003; 74:207-16; PMID:14607248; http://dx.doi.org/10.1016/j.lfs.2003.09.029
   PubMed Web of Science ®Google Scholar
• Marquardt T, Shirasaki R, Ghosh S, Andrews SE, Carter N, Hunter T, Pfaff SL. Coexpressed EphA receptors and Ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 2005; 121:127-39; PMID:15820684; http://dx.doi.org/10.1016/j.cell.2005.01.020
   PubMed Web of Science ®Google Scholar
• Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 2002; 8:35-40; PMID:11786904; http://dx.doi.org/10.1038/nm0102-35
   PubMed Web of Science ®Google Scholar
• Roy R, Wewer UM, Zurakowski D, Pories SE, Moses MA. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem 2004; 279:51323-30; PMID:15381692; http://dx.doi.org/10.1074/jbc.M409565200
   PubMed Web of Science ®Google Scholar
• Kodama T, Ikeda E, Okada A, Ohtsuka T, Shimoda M, Shiomi T, Yoshida K, Nakada M, Ohuchi E, Okada Y. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor. Am J Pathol 2004; 165:1743-53; PMID:15509542; http://dx.doi.org/10.1016/S0002-9440(10)63429-3
   PubMed Web of Science ®Google Scholar
• Ieguchi K, Tomita T, Omori T, Komatsu A, Deguchi A, Masuda J, Duffy SL, Coulthard MG, Boyd A, Maru Y. ADAM12-cleaved ephrin-A1 contributes to lung metastasis. Oncogene 2014; 33:2179-90; PMID:23686306; http://dx.doi.org/10.1038/onc.2013.180
   PubMed Web of Science ®Google Scholar
• Frohlich C, Nehammer C, Albrechtsen R, Kronqvist P, Kveiborg M, Sehara-Fujisawa A, Mercurio AM, Wewer UM. ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression. Mol Cancer Res 2011; 9:1449-61; PMID:21875931; http://dx.doi.org/10.1158/1541-7786.MCR-11-0100
   PubMedGoogle Scholar
• Wei S, Xu G, Bridges LC, Williams P, White JM, DeSimone DW. ADAM13 induces cranial neural crest by cleaving class B Ephrins and regulating Wnt signaling. Dev Cell 2010; 19:345-52; PMID:20708595; http://dx.doi.org/10.1016/j.devcel.2010.07.012
   PubMed Web of Science ®Google Scholar
• Gaultier A, Cousin H, Darribere T, Alfandari D. ADAM13 disintegrin and cysteine-rich domains bind to the second heparin-binding domain of fibronectin. J Biol Chem 2002; 277:23336-44; PMID:11967265; http://dx.doi.org/10.1074/jbc.M201792200
   PubMed Web of Science ®Google Scholar
• Alfandari D, Cousin H, Gaultier A, Smith K, White JM, Darribere T, DeSimone DW. Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration. Curr Biol 2001; 11:918-30; PMID:11448768; http://dx.doi.org/10.1016/S0960-9822(01)00263-9
   PubMed Web of Science ®Google Scholar
• McCusker C, Cousin H, Neuner R, Alfandari D. Extracellular cleavage of cadherin-11 by ADAM metalloproteases is essential for Xenopus cranial neural crest cell migration. Mol Biol Cell 2009; 20:78-89; PMID:18946084; http://dx.doi.org/10.1091/mbc.E08-05-0535
   PubMed Web of Science ®Google Scholar
• Cousin H, Abbruzzese G, Kerdavid E, Gaultier A, Alfandari D. Translocation of the cytoplasmic domain of ADAM13 to the nucleus is essential for Calpain8-a expression and cranial neural crest cell migration. Dev Cell 2011; 20:256-63; PMID:21316592; http://dx.doi.org/10.1016/j.devcel.2010.12.009
   PubMed Web of Science ®Google Scholar
• Krull CE, Lansford R, Gale NW, Collazo A, Marcelle C, Yancopoulos GD, Fraser SE, Bronner-Fraser M. Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. Cu Biol 1997; 7:571-80; PMID:9259560; http://dx.doi.org/10.1016/S0960-9822(06)00256-9
   PubMed Web of Science ®Google Scholar
• Qi B, Newcomer RG, Sang Q-XA. ADAM19Adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases. Curr Pharm Des 2009; 15:2336-48; PMID:19601835; http://dx.doi.org/10.2174/138161209788682352
   PubMedGoogle Scholar
• Yumoto N, Wakatsuki S, Kurisaki T, Hara Y, Osumi N, Frisen J, Sehara-Fujisawa A. Meltrin betaADAM19 interacting with EphA4 in developing neural cells participates in formation of the neuromuscular junction. PloS One 2008; 3:e3322; PMID:18830404; http://dx.doi.org/10.1371/journal.pone.0003322
   PubMedGoogle Scholar
• Solanas G, Cortina C, Sevillano M, Batlle E. Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat Cell Biol 2011; 13:1100-7; PMID:21804545; http://dx.doi.org/10.1038/ncb2298
   PubMed Web of Science ®Google Scholar
• Brennaman LH, Zhang X, Guan H, Triplett JW, Brown A, Demyanenko GP, Manis PB, Landmesser L, Maness PF. Polysialylated NCAM and EphrinAEphA regulate synaptic development of GABAergic interneurons in prefrontal cortex. Cereb Cortex 2013; 23:162-77; PMID:22275477; http://dx.doi.org/10.1093/cercor/bhr392
   PubMedGoogle Scholar
• Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphBephrinB. Cell 2002; 111:251-63; PMID:12408869; http://dx.doi.org/10.1016/S0092-8674(02)01015-2
   PubMed Web of Science ®Google Scholar
• Cortina C, Palomo-Ponce S, Iglesias M, Fernandez-Masip JL, Vivancos A, Whissell G, Humà M, Peiró N, Gallego L, Jonkheer S, et al. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet 2007; 39:1376-83; PMID:17906625; http://dx.doi.org/10.1038/ng.2007.11
   PubMed Web of Science ®Google Scholar
• Chen Y, Fu AKY, Ip NY. Eph receptors at synapses: implications in neurodegenerative diseases. Cell Signal 2012; 24:606-11; PMID:22120527; http://dx.doi.org/10.1016/j.cellsig.2011.11.016
   PubMedGoogle Scholar
• Brennaman LH, Moss ML, Maness PF. EphrinAEphA-induced ectodomain shedding of neural cell adhesion molecule regulates growth cone repulsion through ADAM10 metalloprotease. J Neurochem 2014; 128:267-79; PMID:24117969; http://dx.doi.org/10.1111/jnc.12468
   PubMedGoogle Scholar
• Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007; 8:221-33; PMID:17318226; http://dx.doi.org/10.1038/nrm2125
   PubMed Web of Science ®Google Scholar
• Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004; 4:617-29; PMID:15286728; http://dx.doi.org/10.1038/nri1418
   PubMed Web of Science ®Google Scholar
• Streuli C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 1999; 11:634-40; PMID:10508658; http://dx.doi.org/10.1016/S0955-0674(99)00026-5
   PubMed Web of Science ®Google Scholar
• Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, et al. An essential role for ectodomain shedding in mammalian development. Science 1998; 282:1281-4; PMID:9812885; http://dx.doi.org/10.1126/science.282.5392.1281
   PubMed Web of Science ®Google Scholar
• Palmisano R, Itoh Y. Analysis of MMP-Dependent Cell Migration and Invasion. Meth Molec Bio 2010; 622:379-92.
   Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141:52-67; PMID:20371345; http://dx.doi.org/10.1016/j.cell.2010.03.015
   PubMed Web of Science ®Google Scholar
• Beauchamp A, Lively MO, Mintz A, Gibo D, Wykosky J, Debinski W. EphrinA1 is released in three forms from cancer cells by matrix metalloproteases. Mol Cell Biol 2012; 32:3253-64; PMID:22688511; http://dx.doi.org/10.1128/MCB.06791-11
   PubMed Web of Science ®Google Scholar
• Parri M, Taddei ML, Bianchini F, Calorini L, Chiarugi P. EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res 2009; 69:2072-81; PMID:19244130; http://dx.doi.org/10.1158/0008-5472.CAN-08-1845
   PubMed Web of Science ®Google Scholar
• Kim ES, Kim MS, Moon A. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 2004; 25:1375-82; PMID:15492828
   PubMed Web of Science ®Google Scholar
• Georgakopoulos A, Litterst C, Ghersi E, Baki L, Xu C, Serban G, Robakis NK. MetalloproteinasePresenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J 2006; 25:1242-52; PMID:16511561; http://dx.doi.org/10.1038/sj.emboj.7601031
   PubMed Web of Science ®Google Scholar
• Tanaka M, Sasaki K, Kamata R, Sakai R. The C-terminus of ephrin-B1 regulates metalloproteinase secretion and invasion of cancer cells. J Cell Sci 2007; 120:2179-89; PMID:17567680; http://dx.doi.org/10.1242/jcs.008607
   PubMedGoogle Scholar
• Tanaka M, Kamata R, Yanagihara K, Sakai R. Suppression of gastric cancer dissemination by ephrin-B1-derived peptide. Cancer Sci 2010; 101:87-93; PMID:19804421; http://dx.doi.org/10.1111/j.1349-7006.2009.01352.x
   PubMedGoogle Scholar
• Lee HS, Bong YS, Moore KB, Soria K, Moody SA, Daar IO. Dishevelled mediates ephrinB1 signalling in the eye field through the planar cell polarity pathway. Nat Cell Biol 2006; 8:55-63; PMID:16362052; http://dx.doi.org/10.1038/ncb1344
   PubMed Web of Science ®Google Scholar
• Ogawa K, Wada H, Okada N, Harada I, Nakajima T, Pasquale EB, Tsuyama S. EphB2 and ephrin-B1 expressed in the adult kidney regulate the cytoarchitecture of medullary tubule cells through Rho family GTPases. J Cell Sci 2006; 119:559-70; PMID:16443753; http://dx.doi.org/10.1242/jcs.02777
   PubMed Web of Science ®Google Scholar
• Lin KT, Sloniowski S, Ethell DW, Ethell IM. Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. J Biol Chem 2008; 283:28969-79; PMID:18713744; http://dx.doi.org/10.1074/jbc.M804401200
   PubMedGoogle Scholar
• Moeller ML, Shi Y, Reichardt LF, Ethell IM. EphB receptors regulate dendritic spine morphogenesis through the recruitmentphosphorylation of focal adhesion kinase and RhoA activation. J Biol Chem 2006; 281:1587-98; PMID:16298995; http://dx.doi.org/10.1074/jbc.M511756200
   PubMed Web of Science ®Google Scholar
• Chukkapalli S, Amessou M, Dilly AK, Dekhil H, Zhao J, Liu Q, Bejna A, Thomas RD, Bandyopadhyay S, Bismar TA, et al. Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells. Exp Cell Res 2014; 320:233-46; PMID:24211352; http://dx.doi.org/10.1016/j.yexcr.2013.10.022
   PubMed Web of Science ®Google Scholar
• Litterst C, Georgakopoulos A, Shioi J, Ghersi E, Wisniewski T, Wang R, Ludwig A, Robakis NK. Ligand binding and calcium influx induce distinct ectodomaingamma-secretase-processing pathways of EphB2 receptor. JBiol Chem 2007; 282:16155-63; PMID:17428795; http://dx.doi.org/10.1074/jbc.M611449200
   PubMed Web of Science ®Google Scholar
• Sugiyama N, Gucciardo E, Tatti O, Varjosalo M, Hyytiainen M, Gstaiger M, Gstaiger M, Lehti K. EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion. J Cell Biol 2013; 201:467-84; PMID:23629968; http://dx.doi.org/10.1083/jcb.201205176
   PubMed Web of Science ®Google Scholar
• Suenaga N, Mori H, Itoh Y, Seiki M. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene 2005; 24:859-68; PMID:15558018; http://dx.doi.org/10.1038/sj.onc.1208258
   PubMed Web of Science ®Google Scholar
• Yuan W, Chen Z, Chen Z, Wu S, Guo J, Ge J, Yang P, Huang J. Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo. Neoplasma 2012; 59:105-13; PMID:22103904; http://dx.doi.org/10.4149/neo_2012_014
   PubMed Web of Science ®Google Scholar
• Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness. Biochem Biophys Res Commun 2004; 320:1096-102; PMID:15249202; http://dx.doi.org/10.1016/j.bbrc.2004.06.054
   PubMed Web of Science ®Google Scholar
• Noren NK, Foos G, Hauser CA, Pasquale EB. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 2006; 8:815-25; PMID:16862147; http://dx.doi.org/10.1038/ncb1438
   PubMed Web of Science ®Google Scholar
• Steinle JJ, Meininger CJ, Forough R, Wu G, Wu MH, Granger HJ. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem 2002; 277:43830-5; PMID:12235151; http://dx.doi.org/10.1074/jbc.M207221200
   PubMedGoogle Scholar
• Brown MS, Ye J, Rawson RB, Goldstein JL. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 2000; 100:391-8; PMID:10693756; http://dx.doi.org/10.1016/S0092-8674(00)80675-3
   PubMed Web of Science ®Google Scholar
• Lichtenthaler SF, Haass C, Steiner H. Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing. J Neurochem 2011; 117:779-96; PMID:21413990; http://dx.doi.org/10.1111/j.1471-4159.2011.07248.x
   PubMed Web of Science ®Google Scholar
• Murphy G, Murthy A, Khokha R. Clipping, shedding and RIPping keep immunity on cue. Trends Immunol 2008; 29:75-82; PMID:18182322; http://dx.doi.org/10.1016/j.it.2007.10.009
   PubMed Web of Science ®Google Scholar
• Prox J, Rittger A, Saftig P. Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and Presenilin. Exp Brain Res 2012; 217:331-41; PMID:22120156; http://dx.doi.org/10.1007/s00221-011-2952-0
   PubMed Web of Science ®Google Scholar
• Strooper BD, Annaert W. Presenilins and the intramembrane proteolysis of proteins: facts and fiction. Nat Cell Bio 2001; 3:E221-5.
   PubMed Web of Science ®Google Scholar
• Morohashi Y, Tomita T. Protein trafficking and maturation regulate intramembrane proteolysis. Biochim Biophys Acta 2013; 1828:2855-61; PMID:23770323; http://dx.doi.org/10.1016/j.bbamem.2013.06.001
   PubMedGoogle Scholar
• Rawson RB. Regulated intramembrane proteolysis: from the endoplasmic reticulum to the nucleus. Essays Biochem 2002; 38:155-68; PMID:12463168
   PubMed Web of Science ®Google Scholar
• Nakayama K, Nagase H, Koh C-S, Ohkawara T. γ-secretase-regulated signaling: notch, APP, and Alzheimer's disease. Curr Psychopharmacol 2012; 1:155-66; http://dx.doi.org/10.2174/2211556011201020155
   Google Scholar
• Ni C-Y, Murphy MP, Golde TE, Carpenter G. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001; 294:2179-81; PMID:11679632; http://dx.doi.org/10.1126/science.1065412
   PubMed Web of Science ®Google Scholar
• Wolfe MS. Structure, mechanism and inhibition of gamma-secretase and presenilin-like proteases. Biol Chem 2010; 391:839-47; PMID:20482315; http://dx.doi.org/10.1515/bc.2010.086
   PubMedGoogle Scholar
• Bergmans BA, De Strooper B. γ-secretases: from cell biology to therapeutic strategies. Lancet Neurol 2010; 9:215-26; PMID:20129170; http://dx.doi.org/10.1016/S1474-4422(09)70332-1
   PubMedGoogle Scholar
• Georgakopoulos A, Xu J, Xu C, Mauger G, Barthet G, Robakis NK. Presenilin1gamma-secretase promotes the EphB2-induced phosphorylation of ephrinB2 by regulating phosphoprotein associated with glycosphingolipid-enriched microdomainsCsk binding protein. FASEB J 2011; 25:3594-604; PMID:21746865; http://dx.doi.org/10.1096/fj.11-187856
   PubMedGoogle Scholar
• Playford MP, Schaller MD. The interplay between Src and integrins in normal and tumor biology. Oncogene 2004; 23:7928-46; PMID:15489911; http://dx.doi.org/10.1038/sj.onc.1208080
   PubMed Web of Science ®Google Scholar
• Kanou T, Oneyama C, Kawahara K, Okimura A, Ohta M, Ikeda N, Shintani Y, Okumura M, Okada M. The transmembrane adaptor CbpPAG1 controls the malignant potential of human non–small celllung cancers that have c-Src upregulation. Mol Cancer Res 2011; 9:103-14; PMID:21156787; http://dx.doi.org/10.1158/1541-7786.MCR-10-0340
   PubMedGoogle Scholar
• Grant SG, O’Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 1992; 258:1903-10; PMID:1361685; http://dx.doi.org/10.1126/science.1361685
   PubMed Web of Science ®Google Scholar
• Lu YM, Roder JC, Davidow J, Salter MW. Src activation in the tnduction of long-term potentiation in CA1 hippocampal neurons. Science 1998; 279:1363-8; PMID:9478899; http://dx.doi.org/10.1126/science.279.5355.1363
   PubMed Web of Science ®Google Scholar
• Henderson JT, Georgiou J, Jia Z, Robertson J, Elowe S, Roder JC, Pawson T. The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron 2001; 32:1041-56; PMID:11754836; http://dx.doi.org/10.1016/S0896-6273(01)00553-0
   PubMedGoogle Scholar
• Ionides EL, Fang KS, Rivkah Isseroff R, Oster GF. Stochastic models for cell motion and taxis. J Math Biol 2004; 48:23-37; PMID:14685770; http://dx.doi.org/10.1007/s00285-003-0220-z
   PubMed Web of Science ®Google Scholar
• Danysz W, Parsons CG. Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine–searching for the connections. Br J Pharmacol 2012; 167:324-52; PMID:22646481; http://dx.doi.org/10.1111/j.1476-5381.2012.02057.x
   PubMed Web of Science ®Google Scholar
• Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 2005; 8:1051-8; PMID:16025111; http://dx.doi.org/10.1038/nn1503
   PubMed Web of Science ®Google Scholar
• Inoue E, Deguchi-Tawarada M, Togawa A, Matsui C, Arita K, Katahira-Tayama S, Sato T, Yamauchi E, Oda Y, Takai Y. Synaptic activity prompts gamma-secretase-mediated cleavage of EphA4 and dendritic spine formation. J Cell Biol 2009; 185:551-64; PMID:19414612; http://dx.doi.org/10.1083/jcb.200809151
   PubMed Web of Science ®Google Scholar
• Matsui C, Inoue E, Kakita A, Arita K, Deguchi-Tawarada M, Togawa A, Yamada A, Takai Y, Takahashi H. Involvement of the gamma-secretase-mediated EphA4 signaling pathway in synaptic pathogenesis of Alzheimer's disease. Brain Pathol 2012; 22:776-87; PMID:22404518; http://dx.doi.org/10.1111/j.1750-3639.2012.00587.x
   PubMedGoogle Scholar
• Hedstrom L. Serine protease mechanism and specificity. Chem Rev 2002; 102:4501-24; PMID:12475199; http://dx.doi.org/10.1021/cr000033x
   PubMed Web of Science ®Google Scholar
• Polgar L. The catalytic triad of serine peptidases. Cellular and molecular life sciences : CMLS 2005; 62:2161-72; PMID:16003488; http://dx.doi.org/10.1007/s00018-005-5160-x
   PubMed Web of Science ®Google Scholar
• Netzel-Arnett S, Hooper JD, Szabo R, Madison EL, Quigley JP, Bugge TH, Antalis TM. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev 2003; 22:237-58; PMID:12784999; http://dx.doi.org/10.1023/A:1023003616848
   PubMed Web of Science ®Google Scholar
• M. Santos J, Graindorge A, Soldati-Favre D. New insights into parasite rhomboid proteases. Mol Biochem Parasitol 2012; 182:27-36; PMID:22173057; http://dx.doi.org/10.1016/j.molbiopara.2011.11.010
   PubMedGoogle Scholar
• Lemberg MK, Menendez J, Misik A, Garcia M, Koth CM, Freeman M. Mechanism of intramembrane proteolysis investigated with purified rhomboid proteases. EMBO J 2005; 24:464-72.
   PubMed Web of Science ®Google Scholar
• Lee JR, Urban S, Garvey CF, Freeman M. Regulated intracellular ligand transport and proteolysis control EGF signal activation in drosophila. Cell 2001; 107:161-71; PMID:11672524; http://dx.doi.org/10.1016/S0092-8674(01)00526-8
   PubMed Web of Science ®Google Scholar
• Adrain C, Strisovsky K, Zettl M, Hu L, Lemberg MK, Freeman M. Mammalian EGF receptor activation by the rhomboid protease RHBDL2. EMBO Rep 2011; 12:421-7; PMID:21494248; http://dx.doi.org/10.1038/embor.2011.50
   PubMedGoogle Scholar
• Pascall JC, Brown KD. Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. Biochem Biophys Res Commun 2004; 317:244-52; PMID:15047175; http://dx.doi.org/10.1016/j.bbrc.2004.03.039
   PubMedGoogle Scholar
• Chen ZL, Yoshida S, Kato K, Momota Y, Suzuki J, Tanaka T, Ito J, Nishino H, Aimoto S, Kiyama H, et al. Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J Neurosci 1995; 15:5088-97; PMID:7623137
   PubMed Web of Science ®Google Scholar
• Kishi T, Kato M, Shimizu T, Kato K, Matsumoto K, Yoshida S, Shiosaka S, Hakoshima T. Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis. J Biol Chem 1999; 274:4220-4; PMID:9933620; http://dx.doi.org/10.1074/jbc.274.7.4220
   PubMedGoogle Scholar
• Shiosaka S, Ishikawa Y. Neuropsin—A possible modulator of synaptic plasticity. J Chem Neuroanat 2011; 42:24-9; PMID:21679765; http://dx.doi.org/10.1016/j.jchemneu.2011.05.014
   PubMedGoogle Scholar
• Attwood BK, Bourgognon J-M, Patel S, Mucha M, Schiavon E, Skrzypiec AE, Young KW, Shiosaka S, Korostynski M, Piechota M, et al. Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 2011; 473:372-5; PMID:21508957; http://dx.doi.org/10.1038/nature09938
   PubMed Web of Science ®Google Scholar